Superior efficacy of immunotherapy‐based combinations over monotherapy for EGFR‐mutant non‐small cell lung cancer acquired resistance to EGFR‐TKIs

BACKGROUND: While prospective clinical studies on immunotherapy in epidermal growth factor receptor (EGFR) mutant non‐small‐cell lung cancer (NSCLC) with acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) are ongoing, this study aimed to investigate the outcomes of immunotherapy combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lu, Hao, Xuezhi, Hu, Xingsheng, Wang, Zhijie, Yang, Ke, Mi, Yuling, Yang, Yaning, Xu, Haiyan, Yang, Guangjian, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705617/
https://www.ncbi.nlm.nih.gov/pubmed/33075201
http://dx.doi.org/10.1111/1759-7714.13689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705617/
https://www.ncbi.nlm.nih.gov/pubmed/33075201
http://dx.doi.org/10.1111/1759-7714.13689

Ejemplares similares